Prothena | PRTA - Des Atouts

Prix De L'Action
8.75
Variation Quotidienne
0.21 2.46%
Mensuellement
-3.53%
Annuel
-32.54%
Q1 Prévisions
8.48




Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Akebia Therapeutics USD 376.56M 12.41M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Prothena USD 326.8M 25.82M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xoma USD 263.15M 39.7M 2025-09